OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 02, 2008
With no economic relief in sight, industry, like all of us, is grappling with high-and new-costs.
Providing the right information upfront may ease new requirements to assess solvent levels.
Recent reports discuss the future of pharma's emerging markets.
July 01, 2008
Despite high ambitions for its pharmaceutical and biotech sectors, South Korea still faces a number of hurdles against competing internationally.
How can any company be sure that the standards that suppliers might claim to operate, and might be able to demonstrate from time to time, are actually being practised all the time?
June 26, 2008
Also, Stiefel Laboratories will acquire Barrier Therapeutics, Danube Pharmaceuticals appoints Brian Levy COO, more...
June 19, 2008
Also, Patheon to expand Puerto Rico facility, Creabilis Therapeutics appoints Tony Wilson CEO, more...
Senator Sherrod Brown (D-Ohio), member of the Senate Health, Education and Labor Pensions (HELP) Committee, is requesting additional information from the US Food and Drug Administration and the pharmaceutical industry, concerning the regulation and practice of outsourcing.
June 12, 2008
Also, Shire voluntarily recalls ADHD patch Daytrana
June 05, 2008
Also, Pall plans expansion in South America, Anthony Clarke joins Alexza Pharmaceuticals, more...